Protagonist Therapeutics, Inc (PTGX) Insider Trading Disclosures
Protagonist Therapeutics, Inc (PTGX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PTGX
CIK: 1377121
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerYogesh Ransing
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-09-30 | OWNERSHIP DOCUMENT | 0001104659-26-113279 | View SEC Doc Filr Page |
| 144 | 2026-09-30 | — | 144 Filing | 0001950047-26-009883 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | OWNERSHIP DOCUMENT | 0001104659-26-106831 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | OWNERSHIP DOCUMENT | 0001104659-26-105955 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000908834-26-000405 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | OWNERSHIP DOCUMENT | 0001104659-26-095111 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001968582-26-000805 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000527 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-05 | — | S-8 POS | 0001104659-26-091259 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-05 | — | S-8 POS | 0001104659-26-091257 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-05 | — | S-8 POS | 0001104659-26-091254 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-05 | — | S-8 POS | 0001104659-26-091249 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-05 | — | S-8 POS | 0001104659-26-091245 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-05 | — | S-8 POS | 0001104659-26-091242 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-05 | — | S-8 POS | 0001104659-26-091241 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-05 | — | S-8 POS | 0001104659-26-091239 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-05 | — | S-8 POS | 0001104659-26-091236 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-05 | — | S-8 POS | 0001104659-26-091235 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-05 | — | S-8 POS | 0001104659-26-091233 | View SEC Doc Filr Page |
| S-8 | 2026-08-05 | — | FORM S-8 | 0001104659-26-091226 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001104659-26-091123 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | FORM 8-K | 0001104659-26-091099 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-23 | OWNERSHIP DOCUMENT | 0001104659-26-077761 | View SEC Doc Filr Page |
| 144 | 2026-06-23 | — | 144 Filing | 0001950047-26-006422 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-17 | FORM 8-K | 0001104659-26-075777 | View SEC Doc Filr Page |